Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
Looking for participantsNA

Interoceptive Intervention for Pulmonary Hypertension

Sponsor: Golden Jubilee National Hospital

NCT ID: NCT06443580

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Access to the study treatment being tested
Type of study
Interventional (receives a drug or procedure)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
interoceptive group based intervention (other)
How long the study runs
Study runs about 16 months (dates as stated)
About the drug or intervention
interoceptive group based intervention — other: 8 week online group intervention aiming to improve interoception.
Patient visit burden
Not specified by the sponsor
Type of study
Testing a treatment
Ages
18 Years and over
Who
All
Number of participants
32
Started
2024-06-17
Last checked
2025-03

Plain English Summary

What is this study?

  • • Testing a new treatment for interoception
  • • NA - 32 participants
  • • Background Pulmonary hypertension is a rare and incurable condition characterised by fatigue and breathlessness

Who can take part?

  • • Ages 18 Years and over
  • • Diagnosed with interoception

Where?

  • • Glasgow - Golden Jubilee National Hospital

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

Background Pulmonary hypertension is a rare and incurable condition characterised by fatigue and breathlessness. The effects of pulmonary hypertension has a significant impact on an individual's emotional wellbeing and there are currently no established psychological interventions to improve this. Interoception is defined as the ability to perceive the internal state of the body and emerging research suggests that interventions to improve interoception can improve well-being. Aims The project aims to develop an interoceptive based intervention for those with pulmonary hypertension and examine the feasibility and acceptability of this. Additional aims are to explore the preliminary results of the intervention. Methods A randomised control feasibility trial will be used. Thirty-two participants will be included. Participants will be patients within the Scottish Pulmonary Vascular Unit diagnosed with pulmonary hypertension and randomly assigned to either the intervention or control (waitlist) group. The intervention will be an eight-session online group and participants will complete measures for interoception, anxiety, depression, health related quality of life, as well as a feasibility and acceptability questionnaire. Quantitative analysis will include descriptive statistics and T-tests (including non-parametric versions) to analyse the feasibility and gain a preliminary understanding of the intervention. Practical Applications It is hoped that the findings will identify a sample size for a larger trial whilst also informing future clinical practice. This project will be written up for a suitable journal and will be presented at an appropriate conference.

InteroceptionPulmonary Hypertension

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 18 Years and over
  • Who can join: All genders

What the study is looking for

  • ✓Participants will be patients under the care of the Scottish lung Vascular Unit (SPVU) at the Golden Jubilee...
  • ✓Diagnosed with any type of PH.
  • ✓Adults over 18 years.
  • ✓Fluent in English.
  • ✓Able to commit to the duration of the research (expected to be three months from initial recruitment to the end of...

Who cannot take part

  • ✗Individuals with current thoughts of self-harm or suicide.
  • ✗Presenting with comorbid alcohol or substance misuse.
  • ✗Currently engaging in any additional psychological interventions at the time of the study.
See the full criteria
Inclusion Criteria: * Participants will be patients under the care of the Scottish Pulmonary Vascular Unit (SPVU) at the Golden Jubilee University National Hospital (GJUNH). * Diagnosed with any type of PH. * Adults over 18 years. * Fluent in English. * Able to commit to the duration of the research (expected to be three months from initial recruitment to the end of treatment). Exclusion Criteria: * Individuals with current thoughts of self-harm or suicide. * Presenting with comorbid alcohol or substance misuse. * Currently engaging in any additional psychological interventions at the time of the study.

Where Is This Study? (1 UK site)

Golden Jubilee National Hospital

Glasgow g81 4dy, United Kingdom

Recruiting
Site contact (verified)

How to Get in Touch

Derick Moore

Sponsor contact

CONTACT

+44 07805511803 2021489m@student.gla.ac.uk

Lynne Johnston, Doctorate Clinical Psychology

Sponsor contact

CONTACT

lynne.johnston4@gjnh.scot.nhs.uk
Data sourced from ClinicalTrials.gov · Last verified: 2025-03